A 59-year-old female received a matched related donor stem cell transplant for chronic myelogenous leukemia. After being successfully treated with prednisone for chronic graft versus host disease that initially started 50 days posttransplant, she developed hepatic dysfunction during the steroid taper on day 531, as evidenced by jaundice, elevated liver enzymes, and increased bilirubin. Liver biopsy showed histology suggestive of autoimmune-like hepatitis, which is a rare manifestation of chronic “hepatitic” graft versus host disease.
OgoseTWatanabeTSuzuyaH. Autoimmune hepatitis following allogeneic PBSCT from an HLA-matched sibling. Bone Marrow Transplant. 2003;31:829-832.
2.
TomásJFPinillaIGarcia-BueyML. Long-term liver dysfunction after allogeneic bone marrow transplantation: clinical features and course in 61 patients. Bone Marrow Transplant. 2000;26:649-655.
3.
GranitoAStanzaniMMuratoriL. LKM1-positive type 2 autoimmune hepatitis following allogenic hematopoietic stem-cell transplantation. Am J Gastroenterol. 2008;103:1313-1314.
4.
NaritaAMuramatsuHTakahashiY. Autoimmune-like hepatitis following unrelated BMT successfully treated with rituximab. Bone Marrow Transplant. 2012;47:600-602.
5.
BedossaPPoynardT. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology. 1996;2:289-293.
6.
ShimizuTKasaharaMTanakaK. Living-donor liver transplantation for chronic hepatic graft-versus-host disease. N Engl J Med. 2006;354:1536-1537.
7.
YokoyamaSKasaharaMFukudaA. Successful living-donor liver transplantation for chronic hepatic graft-versus-host disease after bone marrow transplantation for chronic granulomatous disease. Transplantation. 2008;86:367-368.
8.
OrlandoGFerrantASchotsR. Liver transplantation for chronic graft-versus-host disease: case report with 10-year follow-up. Transpl Int. 2005;18:125-129.
9.
MaSYAuWYNgIO. Hepatitic graft-versus-host disease after hematopoietic stem cell transplantation: clinicopathologic features and prognostic implication. Transplantation. 2004;77:1252-1259.
10.
MoriMTabataSHashimotoH. Successful living donor liver transplantation for severe hepatic GVHD histologically resembling autoimmune hepatitis after bone marrow transplantation from the same sibling donor. Transpl Int. 2010;23:e1-e4.
11.
MullighanCGBogdanosDPVerganiDBardyPG. Cytochrome P450 1A2 is a target antigen in hepatitic graft-versus-host disease. Bone Marrow Transplant. 2006;38:703-705.
12.
BarshesNRMyersGDLeeD. Liver transplantation for severe hepatic graft-versus-host disease: an analysis of aggregate survival data. Liver Transpl. 2005;11:525-531.
13.
KrawittEL. Autoimmune hepatitis. N Engl J Med. 2006;354:54-66.
14.
KhalilAZaidmanIBergmanRElhasidRBen-ArushMW. Autoimmune complications after hematopoietic stem cell transplantation in children with nonmalignant disorders. ScientificWorldJournal. 2014;2014:581657.
15.
AlvarezFBergPABianchiFB. International Autoimmune Hepatitis Group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999;31:929-938.
16.
HabibSNalesnikMAAhmadJBuchBarkerDShakilAO. Alloimmune hepatitis following peripheral stem cell transplantation. Bone Marrow Transplant. 2007;39:573-575.
17.
BeleokenESobeskyRLe CaerJP. Immunoproteomic analysis of potentially severe non-graft-versus-host disease hepatitis after allogenic bone marrow transplantation. Hepatology. 2013;57:689-699.
18.
HeneghanMAMcFarlaneIG. Current and novel immunosuppressive therapy for autoimmune hepatitis. Hepatology. 2002;35:7-13.
19.
SantosESArosemenaLRRaezLEO’BrienCRegevA. Successful treatment of autoimmune hepatitis and idiopathic thrombocytopenic purpura with the monoclonal antibody, rituximab: case report and review of literature. Liver Int. 2006;26:625-629.
